Cancer Vaccines
Immunotope, Inc. Receives Second Investment from Ben Franklin Technology Partners of Southeastern PA
Published in Drug Week, July 13th, 2007
Immunotope Inc. announced that Ben Franklin Technology Partners of Southeastern PA (BFTP/SEP) has made a second $350,000 investment to continue funding the company's Phase I IMT- 1012 immunotherapeutic vaccine clinical trial. BFTP/SEP made a first $350,000 investment in August 2006, enabling the company to manufacture the vaccine and obtain necessary regulatory approvals. The second investment will fund patient treatment and evaluation studies.
Immunotope's IMT-1012 multivalent cancer therapeutic vaccine is the first cancer vaccine to combine 12 different novel antigens that each target a different, critical pathway present in highly aggressive ovarian and breast...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
Source: Drug Week (2007-07-13)
More Articles from Drug Week
- Adverse Drug Reactions
Childhood cancer survivors at increased risk of severe health problems as adults - Alcoholism
Smoking may interfere with alcoholics' neurocognitive recovery during abstinence - Amyotrophic Lateral Sclerosis
UCLA, Italian chemists move closer to solving Lou Gehrig's disease mystery - Anemia
Community Oncology explores pitched debate over anemia-fighting drugs - Angioplasty
Angioplasty procedure has potential to damage kidneys, research shows - Biochemistry
Progress toward drug screening with a cell–transistor biosensor - More from this issue of Drug Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
